Topics - Drug Development
Refine By
Content Type
FeaturesBreaking News
Columns
Editorial
Online Exclusives
Industry News
Industry Events
Buyers Guide Companies
Business Corner
Expert's Opinion
White Papers / Tech Papers
Classifieds
Services
Product Releases
Case Studies
Top Companies Report
Jobs
Videos
Collaborations & Alliances
Promotions & Movies
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
Advanced Degrees
Financial Analysis
I Mak
Lowe Down
Managing Your Careeer
Pharma Beat
Preclinical Outsourcing
Salary Survey
Outsourcing Survey
Contracting & Outsourcing
Literature / Brochures
CRO News
FDA Watch
India Report
Executive Perspective
Ask The Board
Glossary
Posters
News Releases
Provider Survey
Conference Sessions
Ask The Experts
Published November 14, 2012
To provide development services at Verona site Read More »
Published November 12, 2012
Includes assets to support IND and BLA Read More »
Published November 9, 2012
Clients include companies from EU, North America, Asia and South America Read More »
By Gregory V. Goldmacher, M.D., Ph.D., ICON Medical Imaging
Published November 9, 2012
Benefits and caveats for sponsors Read More »
By Kevin Maskell, Merck Millipore
Published November 9, 2012
Applying flow cytometry to clinical trial samples Read More »
Published November 8, 2012
Will focus on antibody therapies for inflammatory diseases and cancer Read More »
Published November 8, 2012
Will develop cathepsin inhibitors to treat pain and inflammation Read More »
Published October 29, 2012
Extends Huntington’s collaboration through 2015 Read More »
Published October 23, 2012
Abbott to use ADC technology for oncology targets Read More »
Published October 23, 2012
Supports discovery of antiviral agents for dengue fever Read More »
Published October 18, 2012
Will begin Phase I trials of CUDC-907 Read More »
By Gil Roth
Published October 17, 2012
Three-year pact covers safety assessment, development DMPK Read More »
By Gil Roth
Published October 16, 2012
Animal programs at facilities in WA, TX receive accreditation Read More »
By Gil Roth
Published October 16, 2012
$5 mil. upfront for exclusive license for candidates Read More »
Published October 9, 2012
To develop small molecule inhibitor against aggressive tumors Read More »
